Wednesday, June 18, 2008
Sheraton National Hotel
900 South Orme Street
Arlington, Virginia 22204
8:30 a.m. – 8:45 a.m. Administrative Matters
Call to Order and Conflict of Interest Rules
CAPT Leigh Sawyer, D.V.M., M.P.H.
Executive Director, National Biodefense Science Board
U.S. Department of Health and Human Services
Chair’s Remarks and Agenda Overview
Patricia Quinlisk, M.D., M.P.H.
Chair, National Biodefense Science Board
8:45 a.m. – 9:00 a.m. Opening Remarks
Gerald W. Parker, D.V.M., Ph.D., M.S.
Principal Deputy Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services
9:00 a.m. – 9:30 a.m. Biomedical Advanced Research and Development Authority
Overview
Robin Robinson, Ph.D.
Deputy Assistant Secretary and Director
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
Presentation
Discussion and questions from the Board
9:30 a.m. – 10:30 a.m. Biosurveillance
Introduction
Kenneth L. Dretchen, Ph.D.
Member, National Biodefense Science Board
Update on Homeland Security Presidential Directive 21
Federal Biosurveillance Working Group Activities
CAPT Daniel M. Sosin, M.D., M.P.H., FACP
Director, Biosurveillance Coordination Unit, Coordinating Office for Terrorism Preparedness and Emergency Response
Centers for Disease Control and Prevention
U.S. Department of Health and Human Services
Discussion and questions from the Board
10:30 a.m. – 10:45 a.m. Break - Coffee
10:45 a.m. – 11:30 a.m. Overview of ASTHO Guidance Document: At-Risk Populations and Pandemic Influenza:
Planning Guidance for State, Territorial,Tribal, and Local Health Departments
Introduction
Roberta Carlin, M.S., J.D.
Member, National Biodefense Science Board
Overview
Susan Cooper, M.S.N., R.N.
Commissioner, Tennessee Department of Health
Presentation
Discussion and questions from the Board
11:30 a.m. – 11:45 p.m. Working Group Update – Pandemic Influenza
Remarks
Andrew T. Pavia, M.D.
Chair, Pandemic Influenza Working Group
National Biodefense Science Board
Presentation
Discussion
11:45 a.m. – 12:30 p.m. Personal Preparedness
Introduction
Robin Robinson, Ph.D.
Deputy Assistant Secretary and Director
Biomedical Advanced Research and Development Authority
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
Discussion and questions from the Board
12:30 p.m. – 12:45 p.m. Public Comment
12:45 p.m. – 1:30 p.m. Break – Lunch
1:30 p.m. – 2:15 p.m. Medical Response/Preparedness for Radiological/Nuclear Event
Introduction
Thomas MacVittie, Ph.D.
Member, National Biodefense Science Board
Preparedness and Planning for Radiological and Nuclear Events
C. Norman Coleman, M.D.
Senior Medical Advisor, Office of Preparedness and Emergency Operations, and Associate Director, Radiation Research Program U.S. Department of Health and Human Services
Current Strategies and Future Challenges to the Development of Medical Countermeasure for Radiological and Nuclear Events
Richard J. Hatchett, M.D.
Associate Director for Radiation Countermeasures Research and Emergency Preparedness, National Institute of Allergy and Infectious Diseases, National Institutes of Health
U.S. Department of Health and Human Services
Discussion and questions from the Board
2:15 p.m. – 3:15 p.m. Working Group Updates
U.S. Government Medical Countermeasure R&D Processes for CBRN Agents
Patrick J. Scannon, M.D., Ph.D.
Chair, Medical Countermeasure Research and Development Processes Working Group, National Biodefense Science Board
Markets and Sustainability
John Parker, M.D.
Chair, Markets and Sustainability Working Group
National Biodefense Science Board
Disaster Medicine
James James M.D. Dr.PH., M.H.A
Co-Chair, Disaster Medicine Working Group
National Biodefense Science Board
Stephen Cantrill, M.D.
Co-Chair, Disaster Medicine Working Group
National Biodefense Science Board
3:15 p.m. – 3:30 p.m. Introduction – Subcommittee on Disaster Mental Health
Overview
Patricia Quinlisk, M.D., M.P.H.
Chair, Subcommittee on Disaster Mental Health
Chair, National Biodefense Science Board
3:30 p.m. – 4:15 p.m. Biosecurity Concerns Related to the Synthesis of Select Agents –
An Update on the Activities of the National Science Advisory Board for Biosecurity (NSABB)
Overview
Amy Patterson, M.D.
Executive Director, NSABB and Director, Office of Biotechnology Activities, Office of Science Policy, Office of the Director
National Institutes of Health
U.S. Department of Health and Human Services
Presentation
Discussion and questions from the Board
4:15 p.m. – 4:30 p.m. Future Activities of the Board
Overview
Patricia Quinlisk, M.D., M.P.H.
Chair, National Biodefense Science Board
Discussion
4:30 p.m. – 4:45 p.m. Public Comment
4:45 p.m. – 5:00 p.m. Discussion and Wrap-Up
